USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 195 filers reported holding USANA HEALTH SCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,990 | -13.6% | 56,799 | -7.0% | 0.00% | 0.0% |
| Q2 2023 | $3,851,050 | -13.6% | 61,089 | -13.7% | 0.00% | 0.0% |
| Q1 2023 | $4,454,893 | +24.2% | 70,825 | +5.1% | 0.00% | 0.0% |
| Q4 2022 | $3,587,000 | -0.3% | 67,420 | +5.1% | 0.00% | 0.0% |
| Q3 2022 | $3,597,000 | -30.3% | 64,161 | -10.0% | 0.00% | -50.0% |
| Q2 2022 | $5,158,000 | -0.0% | 71,273 | +9.8% | 0.00% | 0.0% |
| Q1 2022 | $5,159,000 | -17.4% | 64,924 | +5.2% | 0.00% | 0.0% |
| Q4 2021 | $6,247,000 | +5.1% | 61,733 | -4.2% | 0.00% | 0.0% |
| Q3 2021 | $5,942,000 | -6.0% | 64,436 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $6,320,000 | +0.6% | 61,708 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $6,284,000 | +25.3% | 64,381 | -1.1% | 0.00% | 0.0% |
| Q4 2020 | $5,016,000 | +3.2% | 65,071 | -1.4% | 0.00% | 0.0% |
| Q3 2020 | $4,861,000 | -14.6% | 65,993 | -14.9% | 0.00% | 0.0% |
| Q2 2020 | $5,692,000 | -1.2% | 77,508 | -22.3% | 0.00% | -33.3% |
| Q1 2020 | $5,760,000 | -32.2% | 99,698 | -7.8% | 0.00% | -25.0% |
| Q4 2019 | $8,493,000 | +11.2% | 108,130 | -3.2% | 0.00% | +33.3% |
| Q3 2019 | $7,638,000 | +42.0% | 111,682 | +65.1% | 0.00% | +50.0% |
| Q2 2019 | $5,377,000 | +33.7% | 67,665 | +41.1% | 0.00% | 0.0% |
| Q1 2019 | $4,021,000 | -29.4% | 47,949 | -1.0% | 0.00% | -33.3% |
| Q4 2018 | $5,699,000 | -10.4% | 48,422 | -8.3% | 0.00% | +50.0% |
| Q3 2018 | $6,364,000 | -2.6% | 52,798 | -6.8% | 0.00% | -33.3% |
| Q2 2018 | $6,535,000 | +76.8% | 56,674 | +31.7% | 0.00% | +50.0% |
| Q1 2018 | $3,697,000 | +11.9% | 43,040 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $3,305,000 | +24.7% | 44,640 | -2.8% | 0.00% | +100.0% |
| Q3 2017 | $2,650,000 | -12.5% | 45,928 | -2.8% | 0.00% | -50.0% |
| Q2 2017 | $3,027,000 | +17.9% | 47,228 | +6.0% | 0.00% | +100.0% |
| Q1 2017 | $2,567,000 | +12.5% | 44,563 | +19.6% | 0.00% | 0.0% |
| Q4 2016 | $2,281,000 | -14.8% | 37,258 | +92.7% | 0.00% | 0.0% |
| Q3 2016 | $2,676,000 | -16.3% | 19,338 | -32.7% | 0.00% | -50.0% |
| Q2 2016 | $3,199,000 | -55.3% | 28,717 | -51.3% | 0.00% | -50.0% |
| Q1 2016 | $7,163,000 | +22.8% | 58,986 | +29.2% | 0.00% | +33.3% |
| Q4 2015 | $5,833,000 | -16.4% | 45,665 | -12.3% | 0.00% | -25.0% |
| Q3 2015 | $6,981,000 | +30.3% | 52,082 | +32.8% | 0.00% | +33.3% |
| Q2 2015 | $5,359,000 | +942.6% | 39,222 | +745.8% | 0.00% | – |
| Q1 2015 | $514,000 | -0.6% | 4,637 | -7.9% | 0.00% | – |
| Q4 2014 | $517,000 | -24.5% | 5,035 | -45.9% | 0.00% | – |
| Q3 2014 | $685,000 | +17.9% | 9,310 | +25.2% | 0.00% | – |
| Q2 2014 | $581,000 | -31.4% | 7,435 | -33.8% | 0.00% | -100.0% |
| Q1 2014 | $847,000 | +16.7% | 11,235 | +17.0% | 0.00% | – |
| Q4 2013 | $726,000 | -27.0% | 9,605 | -16.2% | 0.00% | -100.0% |
| Q3 2013 | $994,000 | +13.5% | 11,459 | -5.3% | 0.00% | 0.0% |
| Q2 2013 | $876,000 | – | 12,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |